PayPay (PAYP) priced its IPO at $16.00 – $1.00 below the bottom of its $17.00-to-$20.00 range – on Wednesday night, March 11, 2026. SoftBank-backed PayPay, which is Japan’s dominant QR code-based mobile payment app, priced 55 million American Depositary Shares – the number of ADS in the prospectus – at $16.00 each to raise $880 […]
March 11, 2026 Read MoreSoftBank-backed PayPay (PAYP Proposed) – the dominant QR mobile app in Japan – is on center stage this week. The Tokyo-based company is the only large IPO on tap. U.S. stock futures are sliding early today after U.S. oil futures rose 18 percent to about $108 a barrel, their highest level since July 19, 2022, on fear […]
March 9, 2026 Read MoreMiniMed (MMED) priced its IPO at $20.00 – down 20 percent from $25.00, the low end of its range – and sold 28.0 million shares – the number in the prospectus – to raise $560 million on Thursday night, March 5, 2026. MiniMed is the first big IPO to get priced after the U.S. and […]
March 6, 2026 Read MoreAfter the bell today, PayPay (PAYP Proposed) of Japan disclosed the terms for its $1 billion IPO. SoftBank-backed PayPay and a selling shareholder plan to offer 55 million American Depositary Shares (ADS) at a price range of $17.00 to $20.00 to raise $1.02 billion, if the IPO is priced at the $18.50 mid-point of its […]
March 2, 2026 Read MoreOnly one IPO – MiniMed – is braving the chilly winds of March 2026 and the uncertainty of conflict in the Middle East after the U.S. and Israel struck Iran on Saturday (Feb. 28, 2026). Wearable insulin pump pioneer MiniMed (MMED Proposed) is planning to price its large IPO on Wednesday night, March 4, 2026, […]
March 1, 2026 Read MoreAI-driven Generate Biomedicines (GENB) priced its IPO at $16.00 – the mid-point of its range – and sold 25 million shares – the number in the prospectus – to raise $400 million on Thursday night, Feb. 26, 2026. Generate Biomedicines (GENB) shares slid $1.00 to start trading at $15.00 on NASDAQ shortly before 1 p.m. EST […]
February 27, 2026 Read MoreMiniMed (MMED Proposed), a Medtronic spin-off, pulled back the curtain early today on its IPO. The Northridge, California-based company – a pioneer in diabetic care with its wearable automated insulin pump and other devices – is offering 28 million shares at a price range of $25.00 to $28.00 to raise $742 million, if priced at […]
February 24, 2026 Read MoreGenerate Biomedicines, Inc. (GENB Proposed), a clinical biology company developing a treatment for severe asthma, launched its $400 million IPO early today – Monday, Feb. 23, 2026 – for pricing later this week. (Please see the IPO Calendar for the pricing date.) In its S-1/A filing, Generate Biomedicines disclosed the IPO’s terms – 25 million […]
February 23, 2026 Read MoreRank One Computing (ROC) upsized its small IPO at pricing to 4 million shares – up from about 3.71 million shares indicated in an amended filing late this afternoon – and priced the IPO at $6.00 – the top of its range – to raise $24.0 million on Thursday night, Feb. 19, 2026. The deal […]
February 19, 2026 Read MoreFinTech-focused Armada Acquisition Corp. III (AACIU) priced its SPAC IPO on Tuesday night, Feb. 17, 2026, and raised $225 million – as expected. Armada Acquisition III’s SPAC IPO consisted of 22.5 million units at $10.00 each. Armada Acquisition Corp. III (AACIU) slipped in its NASDAQ debut today – Wednesday, Feb. 18, 2026 – opening at […]
February 17, 2026 Read More